Today: 9 April 2026
Subscribe
Browse Category

NASDAQ:CRK 5 January 2026 - 2 February 2026

Natural gas price surges again as Arctic blast looms, lifting UNG and U.S. producers

Natural gas price surges again as Arctic blast looms, lifting UNG and U.S. producers

U.S. natural gas futures jumped about 23% Wednesday to $4.80 per mmBtu as traders bet on a major cold snap, with the Henry Hub contract up 87 cents from Tuesday. The United States Natural Gas Fund rose 8.5% and EQT gained 5%. Weather forecasts signal Arctic cold and possible production freeze-offs in Texas. Coterra and Devon are in early merger talks, according to TradingView.
21 January 2026
·········
Natural gas price stock UNG slides as mild-weather outlook hits U.S. gas futures

Natural gas price stock UNG slides as mild-weather outlook hits U.S. gas futures

U.S. Natural Gas Fund (UNG) dropped 4% to $11.17 as front-month gas futures hit multi-month lows, with NYMEX February gas down 14 cents at $3.38/mmBtu. Traders cited weak heating demand and falling Henry Hub spot prices, which slipped to $2.86/mmBtu after averaging $4.13 in December. Focus shifts to Thursday’s U.S. storage report for further direction. EQT, Antero, and CNX shares also declined.
6 January 2026
······
Comstock Resources stock slides as U.S. gas futures drop on warm-weather outlook

Comstock Resources stock slides as U.S. gas futures drop on warm-weather outlook

Comstock Resources shares dropped 4.2% to $22.60 Monday as U.S. natural gas futures fell over 5% on forecasts for above-normal winter temperatures. Other gas-focused producers also declined, with Antero Resources down 3.8% and Range Resources off 1.8%. Traders cited weaker demand signals and are watching the next U.S. gas-storage update. About 2.2 million Comstock shares traded by midafternoon.
5 January 2026
···

Stock Market Today

  • Guard Therapeutics Faces Potential Delisting from Nasdaq First North Growth Market
    April 9, 2026, 12:06 PM EDT. Guard Therapeutics International AB has been notified by Nasdaq that it currently fails to meet the active operations requirement, risking delisting by June 17, 2026. The company is exploring a merger or reverse acquisition to satisfy Nasdaq's operational criteria. A transaction structure is expected to be proposed in Q2 2024, allowing Nasdaq to reassess the listing status. If no agreement is reached, the board will recommend voluntary delisting and liquidation, returning available funds to shareholders. Final decisions will be taken by shareholders at a general meeting. Guard Therapeutics focuses on developing therapies for kidney diseases based on the alpha-1-microglobulin protein and is listed under the ticker GUARD.

Latest article

Palantir Stock Drops as Michael Burry Says Anthropic Is ‘Eating Its Lunch’

Palantir Stock Drops as Michael Burry Says Anthropic Is ‘Eating Its Lunch’

9 April 2026
Palantir Technologies dropped about 7% Thursday after Michael Burry said Anthropic was overtaking it in enterprise AI, putting Palantir on track to lose $34 billion in market value. Anthropic reported its annualized revenue run rate had surged past $30 billion and launched new AI tools for businesses. Nearly one in four businesses on Ramp now pays for Anthropic, according to Ramp data. Palantir’s stock still trades at 395 times earnings.
Salesforce Stock Hits Fresh 52-Week Low Despite AI Growth and $50 Billion Buyback

Salesforce Stock Hits Fresh 52-Week Low Despite AI Growth and $50 Billion Buyback

9 April 2026
Salesforce shares hit a new 52-week low Thursday, dropping 3.7% to $169.76 despite reporting 12% revenue growth and strong demand for its AI products. The broader software sector continued to slide, with the S&P 500 software and services index down about $1 trillion since January. Salesforce raised its buyback authorization to $50 billion and increased its dividend to 44 cents a share.
ServiceNow Stock Hits Fresh 52-Week Low as Analysts Cut Targets Ahead of Earnings

ServiceNow Stock Hits Fresh 52-Week Low as Analysts Cut Targets Ahead of Earnings

9 April 2026
ServiceNow shares dropped 5.1% to $92.45 by 10:20 a.m. EDT Thursday, hitting a new 52-week low after analysts at Stifel, BTIG, and Goldman Sachs cut price targets citing weak federal spending and limited 2026 growth. The company announced it will integrate AI, data, security, and governance into all products ahead of first-quarter results due April 22.
SoFi Technologies Stock Slips as Wall Street Cuts Targets Ahead of Q1 Earnings

SoFi Technologies Stock Slips as Wall Street Cuts Targets Ahead of Q1 Earnings

9 April 2026
SoFi Technologies shares fell 1.9% to $16.18 Thursday after KBW and Wells Fargo cut price targets ahead of first-quarter results due April 29. The moves follow Muddy Waters’ short position and claims of accounting issues, which SoFi denies. Affirm and LendingClub also traded lower. Barclays and other banks have trimmed targets as concerns mount over credit quality and sector valuations.
Tesla revives cheaper EV bet with compact SUV plan in China after sales strain

Tesla revives cheaper EV bet with compact SUV plan in China after sales strain

9 April 2026
Tesla is developing a smaller, cheaper electric SUV to be built first in Shanghai, sources said. The new model would cost less than the Model 3 and be smaller than the Model Y. Tesla produced 408,386 vehicles but delivered only 358,023 in Q1, as U.S. demand weakened and competition increased. Shares fell 0.8% Thursday.
Go toTop